Lipocine Inc. (LPCN) SEC Filing 8-K Material Event for the period ending Wednesday, March 6, 2019

Lipocine Inc.

CIK: 1535955 Ticker: LPCN

View differences made from one to another to evaluate Lipocine Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Lipocine Inc..


Assess how Lipocine Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Lipocine Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Lipocine Inc. provided additional information to their SEC Filing as exhibits

Ticker: LPCN
CIK: 1535955
Form Type: 8-K Corporate News
Accession Number: 0001144204-19-012435
Submitted to the SEC: Wed Mar 06 2019 8:01:59 AM EST
Accepted by the SEC: Wed Mar 06 2019
Period: Wednesday, March 6, 2019
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: